Senior Director, Market Research, HIV Prevention Integrated Insights at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, Pharmaceuticals, HealthcareIndustries

Requirements

Leadership experience in managing, developing, coaching, and growing high-performing market research teams with competencies in healthcare providers and consumers
Expertise in leading market research strategy, planning, vendor contracts, and functional budget management
Ability to engage with key US marketing and cross-functional stakeholders to develop and execute market research supporting business objectives
Proven experience generating superior customer market research insights, both individually and through direct reports, to provide competitive advantage
HIV Prevention expertise to provide consulting advice on pre- and post-launch brand strategies and marketing tactics
Strong cross-functional leadership skills to manage collaboration processes for insightful market research plans addressing strategic and tactical objectives
Ability to represent the HIV Prevention Integrated Insights function at senior-level meetings and make portfolio recommendations based on marketplace knowledge
Capability to share best practices across teams

Responsibilities

Lead, manage, develop, coach, and grow a high-performing team demonstrating strong market research competencies with healthcare providers and consumers
Lead market research strategy, planning, vendor contracts, and manage the functional budget
Engage with key US marketing and cross-functional stakeholders to develop and execute market research shaping strategies and tactics for business objectives
Generate superior customer market research insights to provide competitive advantage
Provide HIV Prevention expertise and consulting advice for critical business needs, including brand strategies and marketing tactics
Manage cross-functional collaboration to develop insightful market research plans addressing brands’ strategic and tactical requirements
Represent HIV Prevention Integrated Insights at senior-level meetings and make portfolio recommendations
Share best practices across teams

Skills

Market Research

Primary Market Research

HIV Prevention

Integrated Insights

Team Leadership

Biopharmaceuticals

Commercial Strategy

Strategic Planning

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free